Global Multiple Sclerosis Market Insights: Impact of COVID-19 and Future Expectations to 2028

Publisher Name :
Date: 23-May-2023
No. of pages: 123

Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurodegeneration in the central nervous system.

The Multiple Sclerosis market revenue was 13809.22 Million USD in 2022, and will reach 21672.55 Million USD in 2028, with a CAGR of 7.8% during 2022-2028.

This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis industry, and breaks down according to the type, application, and consumption area of Multiple Sclerosis. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Multiple Sclerosis in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the global Multiple Sclerosis market covered in Chapter 11:

Merck KGaA

InnoBioscience

Biogen

GSK

Antisense Therapeutics

AB Science

Actelion

Santhera Pharmaceuticals

Ionis Pharmaceutical

TG Therapeutics

Bayer

Novartis

Sanofi

MedDay

GeNeuro

MediciNova

Celgene

AbbVie

Coherus Bioscience

Alkermes

Teva

Roche

In Chapter 3, on the basis of types, the Multiple Sclerosis market from 2018 to 2028 is primarily split into:

Injectable Agents

Oral Agents

In Chapter 4, on the basis of applications, the Multiple Sclerosis market from 2018 to 2028 covers:

Hospital

Research

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:

North America (Covered in Chapter 6)

United States

Canada

Mexico

Europe (Covered in Chapter 7)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8)

China

Japan

South Korea

Australia

India

Middle East and Africa (Covered in Chapter 9)

Saudi Arabia

UAE

Egypt

South Africa

South America (Covered in Chapter 10)

Brazil

Argentina

Columbia

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Multiple Sclerosis Market Insights: Impact of COVID-19 and Future Expectations to 2028

Table of Content

1 Report Overview
1.1 Research Objectives
1.2 Study Scope
1.3 Key Market Segments
1.4 Market Investment Scenario Strategic

2 Industry Insights
2.1 Industry Ecosystem Analysis
2.1.1 Industry Chain Analysis
2.1.2 Distribution Channel Analysis
2.2 Market Trend Analysis
2.2.1 Growth Drivers
2.2.2 Industry Constraints and Challenges
2.3 Industry Trends Under COVID-19
2.3.1 Risk Assessment on COVID-19
2.3.2 Assessment of the Overall Impact of COVID-19 on the Industry
2.3.3 Pre COVID-19 and Post COVID-19 Market Scenario
2.4 Industry Innovation Prospect Analysis
2.5 The Impact of Covid-19 From the Perspective of Industry Chain

3 Global Multiple Sclerosis Market, By Product Type
3.1 Global Multiple Sclerosis Sales, Revenue and Market Share by Types (2018-2023)
3.1.1 Global Multiple Sclerosis Sales and Market Share by Types (2018-2023)
3.1.2 Global Multiple Sclerosis Revenue and Market Share by Types (2018-2023)
3.1.3 Global Multiple Sclerosis Price by Types (2018-2023)
3.2 Key Trends by Types
3.3 Global Multiple Sclerosis Sales, Price and Growth Rate of Injectable Agents (2018-2023)
3.4 Global Multiple Sclerosis Sales, Price and Growth Rate of Oral Agents (2018-2023)

4 Global Multiple Sclerosis Market, By Applications
4.1 Global Multiple Sclerosis Consumption, Revenue and Market Share by Applications (2018-2023)
4.1.1 Global Multiple Sclerosis Consumption and Market Share by Applications (2018-2023)
4.1.2 Global Multiple Sclerosis Revenue and Market Share by Applications (2018-2023)
4.2 Hospital
4.3 Research

5 Global Multiple Sclerosis Market, By Regions
5.1 Global Multiple Sclerosis Market Sales and Market Share by Regions
5.1.1 Global Multiple Sclerosis Sales by Regions (2018-2023)
5.1.2 Global Multiple Sclerosis Sales Market Share by Regions (2018-2023)
5.2 Global Multiple Sclerosis Market Revenue and Market Share by Regions
5.2.1 Global Multiple Sclerosis Revenue by Regions (2018-2023)
5.2.2 Global Multiple Sclerosis Revenue Market Share by Regions (2018-2023)
5.3 Key Trends by Regions
5.3.1 Emerging Market Analysis

6 North America Multiple Sclerosis Market Analysis
6.1 North America Multiple Sclerosis Market Size
6.1.1 North America Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
6.1.2 North America Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
6.2 U.S. Multiple Sclerosis Market Size
6.3 Canada Multiple Sclerosis Market Size
6.4 Mexico Multiple Sclerosis Market Size
6.5 Key Macroeconomic Indicators
6.6 The Influence of COVID-19 on North America Market

7 Europe Multiple Sclerosis Market Analysis
7.1 Europe Multiple Sclerosis Market Size
7.1.1 Europe Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
7.1.2 Europe Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
7.2 Germany Multiple Sclerosis Market Size
7.3 United Kingdom Multiple Sclerosis Market Size
7.4 France Multiple Sclerosis Market Size
7.5 Italy Multiple Sclerosis Market Size
7.6 Spain Multiple Sclerosis Market Size
7.7 Russia Multiple Sclerosis Market Size
7.8 Key Macroeconomic Indicators
7.9 The Influence of COVID-19 on Europe Market

8 Asia-Pacific Multiple Sclerosis Market Analysis
8.1 Asia-Pacific Multiple Sclerosis Market Size
8.1.1 Asia-Pacific Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
8.1.2 Asia-Pacific Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
8.2 China Multiple Sclerosis Market Size
8.3 Japan Multiple Sclerosis Market Size
8.4 South Korea Multiple Sclerosis Market Size
8.5 Australia Multiple Sclerosis Market Size
8.6 India Multiple Sclerosis Market Size
8.7 Key Macroeconomic Indicators
8.8 The Influence of COVID-19 on Asia Pacific Market

9 Middle East and Africa Multiple Sclerosis Market Analysis
9.1 Middle East and Africa Multiple Sclerosis Market Size
9.1.1 Middle East and Africa Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
9.1.2 Middle East and Africa Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
9.2 Saudi Arabia Multiple Sclerosis Market Size
9.3 UAE Multiple Sclerosis Market Size
9.4 Egypt Multiple Sclerosis Market Size
9.5 South Africa Multiple Sclerosis Market Size
9.6 Key Macroeconomic Indicators
9.7 The Influence of COVID-19 on Middle East and Africa Market

10 South America Multiple Sclerosis Market Analysis
10.1 South America Multiple Sclerosis Market Size
10.1.1 South America Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
10.1.2 South America Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
10.2 Brazil Multiple Sclerosis Market Size
10.3 Argentina Multiple Sclerosis Market Size
10.4 Columbia Multiple Sclerosis Market Size
10.5 Key Macroeconomic Indicators
10.6 The Influence of COVID-19 on South America Market

11 Competition Landscape and Company Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Basic Information
11.1.2 Merck KGaA Product Profiles, Application and Specification
11.1.3 Merck KGaA Multiple Sclerosis Market Performance (2018-2023)
11.2 InnoBioscience
11.2.1 InnoBioscience Basic Information
11.2.2 InnoBioscience Product Profiles, Application and Specification
11.2.3 InnoBioscience Multiple Sclerosis Market Performance (2018-2023)
11.3 Biogen
11.3.1 Biogen Basic Information
11.3.2 Biogen Product Profiles, Application and Specification
11.3.3 Biogen Multiple Sclerosis Market Performance (2018-2023)
11.4 GSK
11.4.1 GSK Basic Information
11.4.2 GSK Product Profiles, Application and Specification
11.4.3 GSK Multiple Sclerosis Market Performance (2018-2023)
11.5 Antisense Therapeutics
11.5.1 Antisense Therapeutics Basic Information
11.5.2 Antisense Therapeutics Product Profiles, Application and Specification
11.5.3 Antisense Therapeutics Multiple Sclerosis Market Performance (2018-2023)
11.6 AB Science
11.6.1 AB Science Basic Information
11.6.2 AB Science Product Profiles, Application and Specification
11.6.3 AB Science Multiple Sclerosis Market Performance (2018-2023)
11.7 Actelion
11.7.1 Actelion Basic Information
11.7.2 Actelion Product Profiles, Application and Specification
11.7.3 Actelion Multiple Sclerosis Market Performance (2018-2023)
11.8 Santhera Pharmaceuticals
11.8.1 Santhera Pharmaceuticals Basic Information
11.8.2 Santhera Pharmaceuticals Product Profiles, Application and Specification
11.8.3 Santhera Pharmaceuticals Multiple Sclerosis Market Performance (2018-2023)
11.9 Ionis Pharmaceutical
11.9.1 Ionis Pharmaceutical Basic Information
11.9.2 Ionis Pharmaceutical Product Profiles, Application and Specification
11.9.3 Ionis Pharmaceutical Multiple Sclerosis Market Performance (2018-2023)
11.10 TG Therapeutics
11.10.1 TG Therapeutics Basic Information
11.10.2 TG Therapeutics Product Profiles, Application and Specification
11.10.3 TG Therapeutics Multiple Sclerosis Market Performance (2018-2023)
11.11 Bayer
11.11.1 Bayer Basic Information
11.11.2 Bayer Product Profiles, Application and Specification
11.11.3 Bayer Multiple Sclerosis Market Performance (2018-2023)
11.12 Novartis
11.12.1 Novartis Basic Information
11.12.2 Novartis Product Profiles, Application and Specification
11.12.3 Novartis Multiple Sclerosis Market Performance (2018-2023)
11.13 Sanofi
11.13.1 Sanofi Basic Information
11.13.2 Sanofi Product Profiles, Application and Specification
11.13.3 Sanofi Multiple Sclerosis Market Performance (2018-2023)
11.14 MedDay
11.14.1 MedDay Basic Information
11.14.2 MedDay Product Profiles, Application and Specification
11.14.3 MedDay Multiple Sclerosis Market Performance (2018-2023)
11.15 GeNeuro
11.15.1 GeNeuro Basic Information
11.15.2 GeNeuro Product Profiles, Application and Specification
11.15.3 GeNeuro Multiple Sclerosis Market Performance (2018-2023)
11.16 MediciNova
11.16.1 MediciNova Basic Information
11.16.2 MediciNova Product Profiles, Application and Specification
11.16.3 MediciNova Multiple Sclerosis Market Performance (2018-2023)
11.17 Celgene
11.17.1 Celgene Basic Information
11.17.2 Celgene Product Profiles, Application and Specification
11.17.3 Celgene Multiple Sclerosis Market Performance (2018-2023)
11.18 AbbVie
11.18.1 AbbVie Basic Information
11.18.2 AbbVie Product Profiles, Application and Specification
11.18.3 AbbVie Multiple Sclerosis Market Performance (2018-2023)
11.19 Coherus Bioscience
11.19.1 Coherus Bioscience Basic Information
11.19.2 Coherus Bioscience Product Profiles, Application and Specification
11.19.3 Coherus Bioscience Multiple Sclerosis Market Performance (2018-2023)
11.20 Alkermes
11.20.1 Alkermes Basic Information
11.20.2 Alkermes Product Profiles, Application and Specification
11.20.3 Alkermes Multiple Sclerosis Market Performance (2018-2023)
11.21 Teva
11.21.1 Teva Basic Information
11.21.2 Teva Product Profiles, Application and Specification
11.21.3 Teva Multiple Sclerosis Market Performance (2018-2023)
11.22 Roche
11.22.1 Roche Basic Information
11.22.2 Roche Product Profiles, Application and Specification
11.22.3 Roche Multiple Sclerosis Market Performance (2018-2023)

12 Global Multiple Sclerosis Market Forecast, By Type and Applications
12.1 Global Multiple Sclerosis Market Forecast by Types (2023-2028)
12.1.1 Global Multiple Sclerosis Market Forecast Sales and Market Share by Types (2023-2028)
12.1.2 Global Multiple Sclerosis Market Forecast Revenue and Market Share by Types (2023-2028)
12.2 Global Multiple Sclerosis Market Forecast by Applications (2023-2028)
12.2.1 Global Multiple Sclerosis Market Forecast Consumption and Market Share by Applications (2023-2028)
12.2.2 Global Multiple Sclerosis Market Forecast Revenue and Market Share by Applications (2023-2028)

13 Global Multiple Sclerosis Market Forecast, By Regions
13.1 Global Multiple Sclerosis Market Forecast Sales and Market Share by Regions (2023-2028)
13.2 Global Multiple Sclerosis Market Forecast Revenue and Market Share by Regions (2023-2028)
13.3 North America Multiple Sclerosis Market Forecast (2023-2028)
13.4 Europe Multiple Sclerosis Market Forecast (2023-2028)
13.5 Asia-Pacific Multiple Sclerosis Market Forecast (2023-2028)
13.6 Middle East and Africa Multiple Sclerosis Market Forecast (2023-2028)
13.7 South America Multiple Sclerosis Market Forecast (2023-2028)

14 Appendix
14.1 Methodology
14.2 Research Data Source
14.2.1 Secondary Data
14.2.2 Primary Data
14.2.3 Market Size Estimation
14.2.4 Legal Disclaimer

List of Tables and Figures

Table Multiple Sclerosis Key Market Segments
Figure Global Multiple Sclerosis Market Size and Growth Rate 2018-2028
Figure Channel Status of Multiple Sclerosis
Table Market Driving Factors of Multiple Sclerosis
Table Market Industry Constraints and Challenges of Multiple Sclerosis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Table Global Multiple Sclerosis Sales by Types (2018-2023)
Table Global Multiple Sclerosis Sales Share by Types (2018-2023)
Table Global Multiple Sclerosis Revenue ($) by Types (2018-2023)
Table Global Multiple Sclerosis Revenue Share by Types (2018-2023)
Table Global Multiple Sclerosis Price by Types (2018-2023)
Figure Global Injectable Agents Sales and Growth Rate (2018-2023)
Figure Global Injectable Agents Price (2018-2023)
Figure Global Oral Agents Sales and Growth Rate (2018-2023)
Figure Global Oral Agents Price (2018-2023)
Table Global Multiple Sclerosis Consumption by Applications (2018-2023)
Table Global Multiple Sclerosis Consumption Share by Applications (2018-2023)
Table Global Multiple Sclerosis Revenue ($) by Applications (2018-2023)
Table Global Multiple Sclerosis Revenue Share by Applications (2018-2023)
Figure Global Hospital Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Research Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Multiple Sclerosis Sales and Growth Rate (2018-2023)
Table Global Multiple Sclerosis Sales by Regions (2018-2023)
Table Global Multiple Sclerosis Sales Market Share by Regions (2018-2023)
Figure Global Multiple Sclerosis Sales Market Share by Regions in 2022
Figure Global Multiple Sclerosis Revenue and Growth Rate (2018-2023)
Table Global Multiple Sclerosis Revenue by Regions (2018-2023)
Table Global Multiple Sclerosis Revenue Market Share by Regions (2018-2023)
Figure Global Multiple Sclerosis Revenue Market Share by Regions in 2022
Figure North America Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Table North America Multiple Sclerosis Sales by Countries (2018-2023)
Figure North America Multiple Sclerosis Market Revenue ($) and Growth Rate (2018-2023)
Table North America Multiple Sclerosis Revenue ($) by Countries (2018-2023)
Figure U.S. Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure U.S. Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Canada Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Canada Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Mexico Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Mexico Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure North America COVID-19 Status
Figure Europe Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Table Europe Multiple Sclerosis Sales by Countries (2018-2023)
Figure Europe Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Table Europe Multiple Sclerosis Revenue by Countries (2018-2023)
Figure Germany Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Germany Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure United Kingdom Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure United Kingdom Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure France Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure France Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Italy Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Italy Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Spain Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Spain Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Russia Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Russia Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Europe COVID-19 Status
Figure Asia-Pacific Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Table Asia-Pacific Multiple Sclerosis Sales by Countries (2018-2023)
Figure Asia-Pacific Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Table Asia-Pacific Multiple Sclerosis Revenue by Countries (2018-2023)
Figure China Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure China Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Japan Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Japan Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure South Korea Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure South Korea Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Australia Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Australia Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure India Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure India Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Table Middle East and Africa Multiple Sclerosis Sales by Countries (2018-2023)
Figure Middle East and Africa Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Multiple Sclerosis Revenue by Countries (2018-2023)
Figure Saudi Arabia Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure UAE Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure UAE Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Egypt Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Egypt Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure South Africa Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure South Africa Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure South America Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Table South America Multiple Sclerosis Sales by Countries (2018-2023)
Figure South America Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Table South America Multiple Sclerosis Revenue by Countries (2018-2023)
Figure Brazil Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Brazil Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Argentina Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Argentina Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Figure Columbia Multiple Sclerosis Market Sales and Growth Rate (2018-2023)
Figure Columbia Multiple Sclerosis Market Revenue and Growth Rate (2018-2023)
Table Merck KGaA Company Profile
Table Merck KGaA Production, Value, Price, Gross Margin 2018-2023
Figure Merck KGaA Production and Growth Rate
Figure Merck KGaA Value ($) Market Share 2018-2023
Table InnoBioscience Company Profile
Table InnoBioscience Production, Value, Price, Gross Margin 2018-2023
Figure InnoBioscience Production and Growth Rate
Figure InnoBioscience Value ($) Market Share 2018-2023
Table Biogen Company Profile
Table Biogen Production, Value, Price, Gross Margin 2018-2023
Figure Biogen Production and Growth Rate
Figure Biogen Value ($) Market Share 2018-2023
Table GSK Company Profile
Table GSK Production, Value, Price, Gross Margin 2018-2023
Figure GSK Production and Growth Rate
Figure GSK Value ($) Market Share 2018-2023
Table Antisense Therapeutics Company Profile
Table Antisense Therapeutics Production, Value, Price, Gross Margin 2018-2023
Figure Antisense Therapeutics Production and Growth Rate
Figure Antisense Therapeutics Value ($) Market Share 2018-2023
Table AB Science Company Profile
Table AB Science Production, Value, Price, Gross Margin 2018-2023
Figure AB Science Production and Growth Rate
Figure AB Science Value ($) Market Share 2018-2023
Table Actelion Company Profile
Table Actelion Production, Value, Price, Gross Margin 2018-2023
Figure Actelion Production and Growth Rate
Figure Actelion Value ($) Market Share 2018-2023
Table Santhera Pharmaceuticals Company Profile
Table Santhera Pharmaceuticals Production, Value, Price, Gross Margin 2018-2023
Figure Santhera Pharmaceuticals Production and Growth Rate
Figure Santhera Pharmaceuticals Value ($) Market Share 2018-2023
Table Ionis Pharmaceutical Company Profile
Table Ionis Pharmaceutical Production, Value, Price, Gross Margin 2018-2023
Figure Ionis Pharmaceutical Production and Growth Rate
Figure Ionis Pharmaceutical Value ($) Market Share 2018-2023
Table TG Therapeutics Company Profile
Table TG Therapeutics Production, Value, Price, Gross Margin 2018-2023
Figure TG Therapeutics Production and Growth Rate
Figure TG Therapeutics Value ($) Market Share 2018-2023
Table Bayer Company Profile
Table Bayer Production, Value, Price, Gross Margin 2018-2023
Figure Bayer Production and Growth Rate
Figure Bayer Value ($) Market Share 2018-2023
Table Novartis Company Profile
Table Novartis Production, Value, Price, Gross Margin 2018-2023
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2018-2023
Table Sanofi Company Profile
Table Sanofi Production, Value, Price, Gross Margin 2018-2023
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2018-2023
Table MedDay Company Profile
Table MedDay Production, Value, Price, Gross Margin 2018-2023
Figure MedDay Production and Growth Rate
Figure MedDay Value ($) Market Share 2018-2023
Table GeNeuro Company Profile
Table GeNeuro Production, Value, Price, Gross Margin 2018-2023
Figure GeNeuro Production and Growth Rate
Figure GeNeuro Value ($) Market Share 2018-2023
Table MediciNova Company Profile
Table MediciNova Production, Value, Price, Gross Margin 2018-2023
Figure MediciNova Production and Growth Rate
Figure MediciNova Value ($) Market Share 2018-2023
Table Celgene Company Profile
Table Celgene Production, Value, Price, Gross Margin 2018-2023
Figure Celgene Production and Growth Rate
Figure Celgene Value ($) Market Share 2018-2023
Table AbbVie Company Profile
Table AbbVie Production, Value, Price, Gross Margin 2018-2023
Figure AbbVie Production and Growth Rate
Figure AbbVie Value ($) Market Share 2018-2023
Table Coherus Bioscience Company Profile
Table Coherus Bioscience Production, Value, Price, Gross Margin 2018-2023
Figure Coherus Bioscience Production and Growth Rate
Figure Coherus Bioscience Value ($) Market Share 2018-2023
Table Alkermes Company Profile
Table Alkermes Production, Value, Price, Gross Margin 2018-2023
Figure Alkermes Production and Growth Rate
Figure Alkermes Value ($) Market Share 2018-2023
Table Teva Company Profile
Table Teva Production, Value, Price, Gross Margin 2018-2023
Figure Teva Production and Growth Rate
Figure Teva Value ($) Market Share 2018-2023
Table Roche Company Profile
Table Roche Production, Value, Price, Gross Margin 2018-2023
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2018-2023
Table Global Multiple Sclerosis Market Forecast Sales by Types (2023-2028)
Table Global Multiple Sclerosis Market Forecast Sales Share by Types (2023-2028)
Table Global Multiple Sclerosis Market Forecast Revenue ($) by Types (2023-2028)
Table Global Multiple Sclerosis Market Forecast Revenue Share by Types (2023-2028)
Table Global Multiple Sclerosis Market Forecast Consumption by Applications (2023-2028)
Table Global Multiple Sclerosis Market Forecast Consumption Share by Applications (2023-2028)
Table Global Multiple Sclerosis Market Forecast Revenue ($) by Applications (2023-2028)
Table Global Multiple Sclerosis Market Forecast Revenue Share by Applications (2023-2028)
Table Global Multiple Sclerosis Market Forecast Sales by Regions (2023-2028)
Table Global Multiple Sclerosis Market Forecast Sales Share by Regions (2023-2028)
Table Global Multiple Sclerosis Market Forecast Revenue ($) by Regions (2023-2028)
Table Global Multiple Sclerosis Market Forecast Revenue Share by Regions (2023-2028)
Figure North America Market Sales and Growth Rate Forecast (2023-2028)
Figure North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Europe Market Sales and Growth Rate Forecast (2023-2028)
Figure Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Sales and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Sales and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure South America Market Sales and Growth Rate Forecast (2023-2028)
Figure South America Market Revenue ($) and Growth Rate Forecast (2023-2028)
  • Global Fingolimod Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Fingolimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Multiple Sclerosis Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Multiple Sclerosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......
  • Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Multiple Sclerosis market: According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years. Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurode......
  • Fingolimod - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 77
    The global Fingolimod market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fingolimod in various end use industries. The expanding demands from the Medical Field, Science Research Field and Other Fields,, are propelling Fingolimod market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inj......
  • Global Fingolimod Market Research Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Fingolimod Professional Survey Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Multiple Sclerosis Drugs, with both qu......
  • Global Multiple Sclerosis Drugs Market Research Report 2023
    Published: 25-Oct-2023        Price: US 2900 Onwards        Pages: 87
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Sclerosis Drugs market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Biogen - Sanofi - Novartis - Teva - Merck KGaA - Bayer - ACORDA - Mallinckrodt Segment by Type - Injectable......
  • Global Multiple Sclerosis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 13-Jun-2023        Price: US 3260 Onwards        Pages: 122
    Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. The Multiple Sclerosis Drugs market revenue was 15099.44 Million USD in 2022, and will reach 23584.78 Million USD in 2028, with a CAGR of 7.72% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclero......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs